Search research articles
Contact Us
Filters
Showing results (51-60 of 96) with videos related to
Page
of 10
Sort By:
Forensic Science International
|
October 25, 2011
The standardization of results on hair testing for drugs of abuse: An interlaboratory exercise in Lombardy Region, Italy
C Stramesi, C Vignali, A Groppi, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
March 29, 2001
13C/12C isotope ratio MS analysis of testosterone, in chemicals and pharmaceutical preparations
X de la Torre, J C González, S Pichini, et al.
Forensic Science International
|
January 26, 2010
Pharmacokinetics of methylphenidate in oral fluid and sweat of a pediatric subject
E Marchei, M Farrè, M Pellegrini, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition
|
April 23, 2005
Prenatal exposure to arecoline (areca nut alkaloid) and birth outcomes
O García-Algar, O Vall, F Alameda, et al.
Drugs Under Experimental and Clinical Research
|
January 1, 1989
Influence of antacids on the bioavailability of glibenclamide
P Zuccaro, R Pacifici, S Pichini, et al.
Journal of Chromatography
|
October 2, 1992
High-performance liquid chromatographic-mass spectrometric assay of busulfan in serum and cerebrospinal fluid
S Pichini, I Altieri, A Bacosi, et al.
Journal of Chromatography
|
November 24, 1993
Determination of nicotine and four metabolites in the serum of smokers by high-performance liquid chromatography with ultraviolet detection
P Zuccaro, I Altieri, M Rosa, et al.
Forensic Science International
|
January 12, 2010
Ethyl glucuronide and ethyl sulfate in meconium and hair-potential biomarkers of intrauterine exposure to ethanol
L Morini, E Marchei, F Vagnarelli, et al.
Anales De Pediatria (Barcelona, Spain : 2003)
|
April 20, 2012
[Alternative biological materials to detect prenatal exposure to drugs of abuse in the third trimester of pregnancy]
J García-Serra, J Ramis, S Simó, et al.
Therapeutic Drug Monitoring
|
March 5, 1998
Issues in methodology and applications for therapeutic drug monitoring of fluoxetine and norfluoxetine enantiomers
P Zuccaro, R Pacifici, I Altieri, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 96) with videos related to
Sort By:
Page
of 10
Forensic Science International
|
October 25, 2011
The standardization of results on hair testing for drugs of abuse: An interlaboratory exercise in Lombardy Region, Italy
C Stramesi, C Vignali, A Groppi, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
March 29, 2001
13C/12C isotope ratio MS analysis of testosterone, in chemicals and pharmaceutical preparations
X de la Torre, J C González, S Pichini, et al.
Forensic Science International
|
January 26, 2010
Pharmacokinetics of methylphenidate in oral fluid and sweat of a pediatric subject
E Marchei, M Farrè, M Pellegrini, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition
|
April 23, 2005
Prenatal exposure to arecoline (areca nut alkaloid) and birth outcomes
O García-Algar, O Vall, F Alameda, et al.
Drugs Under Experimental and Clinical Research
|
January 1, 1989
Influence of antacids on the bioavailability of glibenclamide
P Zuccaro, R Pacifici, S Pichini, et al.
Journal of Chromatography
|
October 2, 1992
High-performance liquid chromatographic-mass spectrometric assay of busulfan in serum and cerebrospinal fluid
S Pichini, I Altieri, A Bacosi, et al.
Journal of Chromatography
|
November 24, 1993
Determination of nicotine and four metabolites in the serum of smokers by high-performance liquid chromatography with ultraviolet detection
P Zuccaro, I Altieri, M Rosa, et al.
Forensic Science International
|
January 12, 2010
Ethyl glucuronide and ethyl sulfate in meconium and hair-potential biomarkers of intrauterine exposure to ethanol
L Morini, E Marchei, F Vagnarelli, et al.
Anales De Pediatria (Barcelona, Spain : 2003)
|
April 20, 2012
[Alternative biological materials to detect prenatal exposure to drugs of abuse in the third trimester of pregnancy]
J García-Serra, J Ramis, S Simó, et al.
Therapeutic Drug Monitoring
|
March 5, 1998
Issues in methodology and applications for therapeutic drug monitoring of fluoxetine and norfluoxetine enantiomers
P Zuccaro, R Pacifici, I Altieri, et al.
Page
of 10